Genflow Biosciences (GENF) Competitors GBX 1.52 -0.01 (-0.65%) (As of 12/20/2024 09:57 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors GENF vs. AOR, RLM, NSCI, ONC, SNG, BVX, APTA, CIZ, FAB, and ROQShould you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include AorTech International (AOR), Realm Therapeutics (RLM), NetScientific (NSCI), Oncimmune (ONC), Synairgen (SNG), BiVictriX Therapeutics (BVX), Aptamer Group (APTA), Cizzle Biotechnology (CIZ), Fusion Antibodies (FAB), and Roquefort Therapeutics (ROQ). These companies are all part of the "biotechnology" industry. Genflow Biosciences vs. AorTech International Realm Therapeutics NetScientific Oncimmune Synairgen BiVictriX Therapeutics Aptamer Group Cizzle Biotechnology Fusion Antibodies Roquefort Therapeutics Genflow Biosciences (LON:GENF) and AorTech International (LON:AOR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Does the media favor GENF or AOR? In the previous week, Genflow Biosciences' average media sentiment score of 0.00 equaled AorTech International'saverage media sentiment score. Company Overall Sentiment Genflow Biosciences Neutral AorTech International Neutral Which has stronger valuation & earnings, GENF or AOR? AorTech International has higher revenue and earnings than Genflow Biosciences. Genflow Biosciences is trading at a lower price-to-earnings ratio than AorTech International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenflow BiosciencesN/AN/A-£1.53M-£0.01-152.00AorTech International£539K0.00N/A-£3.70N/A Do insiders and institutionals have more ownership in GENF or AOR? 9.2% of Genflow Biosciences shares are owned by institutional investors. 64.2% of Genflow Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is GENF or AOR more profitable? AorTech International has a net margin of 0.00% compared to Genflow Biosciences' net margin of -256.07%. AorTech International's return on equity of 0.00% beat Genflow Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Genflow Biosciences-256.07% -118.88% -58.66% AorTech International N/A N/A N/A Does the MarketBeat Community believe in GENF or AOR? AorTech International received 77 more outperform votes than Genflow Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformGenflow BiosciencesN/AN/AAorTech InternationalOutperform Votes7767.54% Underperform Votes3732.46% SummaryAorTech International beats Genflow Biosciences on 6 of the 9 factors compared between the two stocks. Ad Wealthpin ProVacuum up cash with these special trades? Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. Get Genflow Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENF vs. The Competition Export to ExcelMetricGenflow BiosciencesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£5.32M£165.68M£5.14B£1.92BDividend YieldN/A3.64%5.09%5.45%P/E Ratio-152.00115.5189.971,880.82Price / SalesN/A18,531.021,116.34397,035.90Price / Cash3.0012.8743.1028.78Price / BookN/A8.594.782.81Net Income-£1.53M-£20.67M£120.31M£156.11M7 Day Performance-5.00%-1.05%-1.92%-2.03%1 Month Performance-10.59%174.77%13.65%21.85%1 Year Performance7.80%134.18%28.34%30.10% Genflow Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENFGenflow BiosciencesN/AGBX 1.52-0.7%N/A+7.1%£5.32MN/A-152.005Gap DownAORAorTech InternationalN/AGBX 123.50-2.4%N/AN/A£19.99M£539,000.00-33.383RLMRealm TherapeuticsN/AGBX 11.50flatN/AN/A£13.41M£501,919.00-0.66N/ANSCINetScientificN/AGBX 53.50flatN/AN/A£12.81M£1.45M-486.3626ONCOncimmuneN/AGBX 15.85+8.1%N/A-41.3%£11.75M£1.21M-528.3352Gap UpSNGSynairgenN/AGBX 4.24-3.1%N/A-70.1%£8.55M£79,000.00-144.7334Gap DownBVXBiVictriX TherapeuticsN/AGBX 10+17.6%N/AN/A£8.25MN/A-250.0017Gap UpHigh Trading VolumeAPTAAptamer GroupN/AGBX 0.39-0.3%N/A-69.6%£7.57M£1.03M-4.7837Positive NewsGap DownCIZCizzle BiotechnologyN/AGBX 1.75+2.3%N/A-14.6%£6.94M£25,000.00-175.004Gap UpFABFusion AntibodiesN/AGBX 6.60+2.3%N/A+53.1%£6.29M£1.14M-167.4048ROQRoquefort TherapeuticsN/AGBX 4.50flatN/A-45.9%£5.81M£637.00-450.009 Related Companies and Tools Related Companies AOR Competitors RLM Competitors NSCI Competitors ONC Competitors SNG Competitors BVX Competitors APTA Competitors CIZ Competitors FAB Competitors ROQ Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:GENF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
